Table Of Content

Subject Index, 1992 National Conference on Gynecologic Cancers, 18, 126 Vol. 42, Nos. 1-6 National Conference on Support and Seif- Help Groups, 192 Recommendations for the Early Detection of Cancer in Asymptomatic People, Summary, 45 aA Announcements American Cancer Society Great American Acknowledgment to Reviewers, Smokeout, 282 1991-192, 366 American Cancer Society National Conference on Cancer Prevention and Acquired immunodeficiency syndrome Early Detection, 255 (AIDS)-associated malignancy (See a/so American Cancer Society National Human immunodeficiency virus [HIV]) Conference on Gynecologic Cancers, Expanding challenge of, 69-73 18, 126 Malignant neoplasms and, 74-95 American Cancer Society National Conference on Support and Self- Help Acute lymphoblastic leukemia, childhood Groups, 192 cancer, long-term survivors of, 276-277 Annual Review of Patient Care Reports: Findings from the National Cancer Data Acute lymphocytic leukemia, survival Base, 256 rates, 37 International Union Against Cancer Fellowships, 372 Acute myeloid leukemia, survival rates, 37 Reach to Recovery Conference, 46 Adenocarcinoma, tumors of unknown origin, Anorectal carcinoma, human 99-103 immunodeficiency virus (HIV), malignant neoplasms associated with, 89—90 African Americans Cancer in, 5—6 (Guest Editorial) Autologous bone marrow transplantation/ Statistics, 7-17 chemeotherapy trials, ovarian cancer chemotherapy, 340-341 Age level Cigarette smoking, African Americans, 14 Autopsy, in oncology (Opinion), 47-56 Colonoscopy complications, in elderly, 359 Early cancer detection/prevention, Axillary freckling, neurofibromatoses, 243 American Cancer Society, Guidelines for the Cancer-Related Checkup, 44 Axillary lymph node metastases, tumors of Mortality, 25, 26, 27 unknown origin, adenocarcinoma, 101-102 Mortality, lung cancer, African Americans, 8-9 AIDS (See Acquired immunodeficiency syndrome [AIDS]}) Alpha-interferon, ovarian cancer, biologic Barium enema, colonoscopy and, 352-354 therapy, 341-342 B cell lymphoma, human immunodeficiency American Cancer Society virus (HIV), malignant neoplasms associated Clinical Awards, A6, 64 with, 82-84 Colorectal cancer, revision in recommendations for early detection of, Biliary tract cancer 296-299 Incidence, 30 Great American Smokeout, 282 Mortality, 31 Guidelines for the Cancer-Related Checkup, 44 Biologic therapy, ovarian cancer, 341-343 Guidelines on Screening for Breast Cancer: An Overview, 177-180 Biopsy National Conference on Cancer Prevention Colonoscopy, 1087 and Early Detection, 255 Ewing’s sarcoma, 304 VOL. 42,NO.6 NOVEMBER/DECEMB1E9R92 Blood cancer e Incidence, 30 Mortality, 31 Café-au-lait spots, neurofibromatoses, 242-243 Bone cancer Ewing’s sarcoma, 300-320 Carboplatin, ovarian cancer chemotherapy, Incidence, 30 332-334 Mortality, 31 Skeletal metastases, tumors of unknown ; g , . origin, adenocarcinoma, 102 Carcinoma, poorly differentiated carcinoma, Survival rates, 37 tumors of unknown origin, 106-113 Cardiac complications, childhood cancer, Bowel perforation, colonoscopy long-term survivors of, 269-270, 271 complications, 359-360 J Central nervous system cancer Brain cancer childhood leukemia, neuropsychological Incidence, 30 and psychosocial effects of treatment, Mortality, 25, 31 283-295 Mortal¢ ity, African Americans, 12, 13 Incidence, 30 Survival rates, 37, 38 Lymphoma (PCL), human immunodeficiency virus (HIV), Breast cancer (female) malignant neoplasms associated with, American Cancer Society Guidelines 84-85 on Screening for Breast Cancer: Mortality, 25, 31 An Overview, 177-180 Survival rates, 37, 38 Correction, role of chemotherapy in management of, 43 Cervicai cancer Incidence, 21 . 30, 33; 128 Incidence, 30 Incidence, African Americans, 7, 9 Mortality, 31 Mortality, 21, 25, 28, 31, 32, 35 Staging, African Americans, 15 Mortality, African Americans, 7, 11, 13 Staging, diagnosis, 23 Screening project, design and Survival rates, 22, 38 implementation of community-based, 163-176 Cervical dysplasia, human Staging, African Americans, 15 immunodeficiency virus (HIV), malignant Staging, diagnosis, 23 neoplasms associated with, 89-90 Standards for breast-conservation treatment, 134-162 Standards for breast-conservation ae cology (Opinion), 49 (editorial) landmark report, 133 Childhood cancer, late adverse effects of Surgical management of, regional wea of, ee _ Childhood cancer, leukemia, are neuropsychological and psychosocial effects of treatment, 283-295 Breast cancer (male) Childhood cancer, long-term survivors of, Incidence, 30 evaluation and identification of sequelae Mortality, 31 of treatment, 263-282 Ewing’s sarcoma, 314-317 Breast-conservation treatment, 134-162 Ovarian cancer, 325-326 (Guest Follow-up care, 155-156 Editorial), 332-341 Future research, 156-157 Tumors of unknown origin, 102, 103, Irradiation techniques, 146-155 107-109 Literature review, 134-138 Patient selection and evaluation, 138-143 Childhood cancer Technical aspects of surgical treatment, Bone cancer, Ewing’s sarcoma, 300-320 143-146 Late adverse effects of treatment among patients cured of, 261—262 (Guest Bronchial cancer Editorial) Staging, African Americans, 15 Leiomyosarcoma, human Survival rates, 38 immunodeficiency virus (HIV), CA-A CANCER JOURNAL FOR CLINICIANS malignant neoplasms associated Colonoscopy, 350-365 with, 90 Assistants in, 361-362 Long-term survivors, 263-282 Barium enema and, 352-354 Long-term survivors, cardiac Cleaning and disinfecting, 362 complications, 269-270 Complications of, 359-360 Long-term survivors, dental complications, Contraindications for, 358-359 275 Endoscopic therapy, 357-358 Long-term survivors, endocrine Future uses, 362-363 complications, 263-269 Historical overview, 350 Long-term survivors, eye complications, Indications for, 354-357 274-275 Indications for, abnormal barium enema, Long-term survivors, gastrointestinal/liver 354 complications, 273-274 Indications for, infectious colitis, 355 Long-term survivors, neuropsychological Indications for, inflammatory bowel complications, 269 disease, 354-355 Long-term survivors, pulmonary Indications for, perioperative endoscopy, complications, 270-272 355-356 Long-term survivors, recommendations, Indications for, surveillance, 356 277 Indications for, unexplained chronic Long-term survivors, renal/urologic diarrhea, 356-357 complications, 272—273 Indications for, unexplained colonic Long-term survivors, second cancers, bleeding, 354 275-277 Instrumentation, 350-351 Long-term survivors of, overview, 263 Medication for, 360-361 Mortality, 36 Polypectomy technique, 361 Survival rates, 37 Techniques of, 361 Training in use of, 351-352 Childhood leukemia, neuropsychological and psychosocial effects of treatment, 283-295 Colorectal cancer central nervous system prophylaxis, American Cancer Society, revision in 283-287 recommendations for early detection of, central nervous system relapse, increased 296-299 effects due to, 289 Colonoscopy, 355, 356, 358 chemotherapy, effects of systemic, Incidence, 21, 30, 33, 128 287-289 Incidence, African Americans, 7,9 overview, 283 Mortality, 21, 25, 28, 29, 31, 32, 34 psychosocial effects, 289-292 Mortality, African Americans, 7, 10, 11, 12,13 Cigarette smoking Staging, African Americans, 15 Mortality, African Americans, 8-9 Staging, diagnosis, 23 Prevalence, African Americans, 14 Survival rates, 22, 38 Classics in Oncology Spectrophotometer: New instrument for Connective tissue cancer Ultrarapid Cell Analysis, 60-63 Incidence, 30 Spectrophotometer: New Instrument for Mortality, 25, 31 Ultrarapid Cell Analysis, Introduction, 57-59 Correction Clinical trials Breast cancer (female), role of Autopsy in oncology (Opinion), 51 chemotherapy in management of, 43 Breast-conservaiion treatment, Cancer statistics, 1992, 127, 128 134-135, 138 Cancer statistics for African Americans, author’s correction, 125 Cognition, childhood leukemia, Human immunodeficiency virus (HIV), neuropsychological and psychosocial effects malignant neoplasms associated with, of treatment, 283-295 74-95 Coionic bieeding, unexplained, colonoscopy indications, 354 Crohn’s disease, colonoscopy, 355 VOL. 42,NO.6 NOVEMBER/DECEMBER 1992 D Breast cancer (female), screening project, design and implementation of community-based, 163-176 Dental complications, childhood cancer, Breast cancer (female), statewide long-term survivors of, 274-275 detection and awareness program, using a population-based cancer Dermatofibrosarcoma protuberans, reporting system to evaluate, 367—371 116-125 Ovarian cancer, 325-326 (Guest Editorial) Clinical findings in, 117-118 Course and treatment of, 121-123 Editorials Differential diagnosis of, 119-121 Cancer in African Americans, 5-6 Gross findings in, 118 (Guest Editorial) Histogenesis of, 123 Cancer of the Ovary, 325-326 Incidence of, 116-117 (Guest Editorial) Microscopic findings in, 118-119 Late Adverse Effects of Treatment Among Patients Cured of Cancer During Diagnosis (See also Early cancer detection/ Childhood, 261-262 (Guest Editorial) prevention) Prostate Cancer Screening and Treatment: Autopsy in oncology (Opinion), 49, 52 The American Cancer Society’s Breast cancer (female), staging, 23 Commitment, 197 Cervical cancer, staging, 23 Standards for Breast-Conservation Colorectal cancer, staging, 23 Treatment: A Landmark Report, 133 Dermatofibrosarcoma protuberans, differential diagnosis, 119-121 Elderly, colonoscopy complications, 359 (See Ewing’s sarcoma, 302-304 also Age level) Ovarian cancer, immunodiagnosis, 343 Prostate cancer, diagnosis and work- up, 223-224 Electron microscopy, tumors of unknown Prostate cancer, screening and treatment, origin, 98 American Cancer Society’s commitment, 197 (Editorial) Endocrine cancer Prostate cancer, screening for, current Incidence, 30 trends and future implications, 198-211 Mortality, 25, 31 Race differences, staging, local stage Survival rates, 38 diagnosis, 15 Endocrine complications, childhood cancer, Diarrhea, unexplained chronic, colonoscopy, long-term survivors of, 263-269 indications, 356-357 Endoscopic therapy, colonoscopy, 357-358 Digitial rectal examination, prostate cancer, (See also Colonoscopy) screening for, 199-200 Epidemiology Breast cancer (female), screening project, design and implementation of, 163 E Breast cancer (female), statewide detection and awareness program, Early cancer detection/prevention using a population-based cancer American Cancer Society, colorectal reporting system to evaluate, 367-371 cancer, revision in recommendations for Dermatofibrosarcoma protuberans, early detection of, 296—299 116-117 American Cancer Society Guidelines for Ewing’s sarcoma, 300 the Cancer-Related Checkup, 44 Ovarian cancer, screening and treatment, American Cancer Society Guidelines on 327 Screening for Breast Cancer: An Overview, 177-180 Epstein-Barr virus (EBV), acquired American Cancer Society National immunodeficiency syndrome (AIDS), HIV- Conference on Cancer Prevention and associated malignancies, 70, 71, 82-84 Early Detection, 255 American Cancer Society Esophageal cancer Recommendations for the Early Incidence, 30 Detection of Cancer in Asymptomatic Incidence, African Americans, 9 People, Summary, 45 Mortality, 25, 29, 31 CA-A CANCER JOURNAL FOR CLINICIANS Mortality, African Americans, 7, 8, 10, 12, Grief assuagement, autopsy in oncology 13 (Opinion), 53 Staging, diagnosis, 23 Survival rates, 38 Growth Childhood cancer, long-term survivors of, Etoposide, Ewing’s sarcoma, 317 263-269 Neurofibromatoses, 246-247 Ewing’s sarcoma, 300-320 Biopsy, 304 Clinical features, 300-302 Diagnostic evaluation, 302-304 H Overview of, 300 Pathology and biology, atypical, 309-310 Heart, cardiac complications, childhood Pathology and biology, typical, 305-309 cancer, long-term survivors of, 269-270, 271 Treatment, 311-318 Hemorrhage, colonoscopy complications, Eye 360 Childhood cancer, long-term survivors of, 274-275 Hexamethyimelamine, ovarian cancer Neurofibromatoses, 244-245 chemotherapy, 336-337 Eye cancer Hodgkin’s disease Incidence, 30 Childhood cancer, long-term survivors of, Mortality, 31 276 Human immunodeficiency virus (HIV), malignant neoplasms associated with, 85-86, 87, 88, 89 FE Incidence, 30 Mortality, 25, 31 Freckling Mortality, African Americans, 13 Neurofibromatoses, 243 Survival rates, 37, 38 Hormonal therapy, ovarian cancer, 341 G Human immunodeficiency virus (HIV)-associated malignancy, 74-95 Gamma-interferon, ovarian cancer, biologic anorectal carcinoma, 89-90 therapy, 342 central nervous system lymphoma, 84-85 cervical dysplasia, 89-90 Gastrointestinal complications, childhood expanding challenge of AIDS, 69-73 cancer, long-term survivors of, 273-274 Hodgkin’s disease, 85-86, 87, 88, 89 Kaposi’s sarcoma, 74—77 Genetics leiomyosrcoma (smooth muscle tumor), 90 Neurofibromatoses, 248-249, 251-252 lymphomas, 82-84 Ovarian cancer, screening, 328-329 non-Hodgkin’s lymphoma, 77-82 Tumors of unknown origin, 98-99 T-cell lymphoma, 86, 89 Geographical differences Breast cancer (female), surgical management of, 39-43 Statistics, 32, 33, 34, 35, 128 Statistics (African Americans), 9, 14 lfosfamide Ewing’s sarcoma, 317 Glioma, optic nerve and visual pathway Ovarian cancer chemotherapy, 336 gliomas, neurofibromatoses, 245-246 Immunodiagnosis, ovarian cancer, 343 Gonadal dysfunction, childhood cancer, long-term survivors of, 265-267 Immunoperoxidase tumor staining, tumors of unknown origin, 97-98 Graiiulocytic leukemia Incidence, 30 Impotency, prostatectomy (radical), Mortality, 31 procedure described, 220-221 VOL. 42,NO.6 NOVEMBER/DECEMBER 1992 Infectious colitis, colonoscopy indications, Liver cancer 355 Incidence, 30 Mortality, 28, 29, 31 Inflammatory bowel disease, colonoscopy, Staging, diagnosis, 23 354-355 Survival rates, 22, 38 Irradiation (See Radiation therapy) Lung, pulmonary complications, childhood cancer, long-term survivors of, 270-272 Lung cancer K Incidence, 21, 30, 33, 128 Incidence, African Americans, 7, 9 Mortality, 21, 25, 28, 29, 31, 32, 35 Kaposi's sarcoma (KS), acquired Mortality, African Americans, 7, 8, 10, 11, immunodeficiency syndrome (AIDS), HIV- 12,13 associated malignancies, 69-73, 74-77 Staging, African Americans, 15 Staging, diagnosis, 23 Kidney, childhood cancer complications, Survival rates, 22, 38 long-term survivors of, 272-273 Lymph cancer Kidney cancer Incidence, 30 Incidence, 30 Mortality, 31 Mortality, 25, 31 Mortality, African Americans, 8, 12, 13 Lymph node metastases Survival rates, 38 axillary, tumors of unknown origin, adenocarcinoma, 101-102 prostate cancer, evaluation and radiotherapeutic management of, L 224-227 Laparotomy, ovarian cancer, screening, 330 Lymphocytic leukemia Incidence, 30 Laryngeal cancer Mortality, 31 Incidence, 30 Incidence, African Americans, 9 Lymphoma Mortality, 31 B cell lymphoma, human Mortality, African Americans, 8, 12, 13 immunodeficiency virus (HIV), Staging, African Americans, 15 malignant neoplasms associated with, Survival rates, 38 82-84 Central nervous system lymphoma (PCL), Leiomyosarcoma, human immunodeficiency human immunodeficiency virus (HIV), virus (HIV), malignant neoplasms associated malignant neoplasms associated with, with, 90 84-85 Leukemia Lymphoma (non-Hodgkin’s) Acute lymphoblastic leukemia, childhood Acquired immunodeficiency syndrome cancer, long-term survivors of, 276-277 (AIDS), HIV-associated malignancies, Childhood cancer, late adverse effects of 69-73 treatment among patients cured of, Human immunodeficiency virus (HIV), 261-262 (Guest Editorial) malignant neoplasms associated with, Incidence, 21, 33, 128 77-84 incidence, African Americans, 9 Incidence, 21, 30 Mortality, 21, 25, 28, 29, 31, 32,35 Incidence, African Americans, 9 Mortality, African Americans, 13 Mortality, 21, 25, 31 Survival rates, 37, 38 Mortality, African Americans, 12, 13 Survival rates, 37, 38 Lip cancer Incidence, 30 Mortality, 31 Liver, childhood cancer complications, long- term survivors of, 274 Macrocephaly, neurofibromatoses, 247 CA-A CANCER JOURNAL FOR CLINICIANS Magnetic resonance imaging National Health Interview Survey (NHIS), (See Radiology) African Americans, 14 Mammography (See also Radiology; Neoplasm, poorly differentiated neoplasm, Ultrasonography) tumors of unknown origin, 96-99 American Cancer Society Guidelines on Screening for Breast Cancer: Neuroblastoma, survival rates, 37 An Overview, 177-180 Breast-conservation treatment, 141, Neurofibromatoses, 241-254 155-156, 161-162 Axillary freckling, 243 Screening project, design and Café-au-lait spots, 242-243 implementation of community-based, Cancers, 247-248 163-176 Diagnostic criteria, 242 Statewide Breast Cancer Detection and Genetics and, 248-249, 251-252 Awareness program, use in, 368 Growth and, 246-247 History of, 241-242 Mastectomy Macrocephaly, 247 Breast cancer (female), surgical Neurofibroma types, 243-244 management of, regional differences, Neurologic complications, 247 39-43 NF-2, 249-252 Standards for breast-conservation Ophthalmologic manifestations, 244-245 treatment, 134-162 Optic nerve and visual pathway gliomas, Standards for breast-conservation 245-246 treatment, landmark report, 133 Orthopedic manifestations, 246 (Editorial) Overview, 241-241 Vascular disease, 248 Medical education Autopsy in oncology (Opinion), 52-53 Neurologic complications, Colonoscopy, training in use of, neurofibromatoses, 247 1075-1077 Neuropsychological complications Melanoma of skin Childhood cancer, long-term survivors Incidence, 21, 30, 33, 128 of, 269 Mortality, 21, 31, 32 Childhood leukemia, neuropsychological Staging, diagnosis, 23 and psychosocial effects of treatment, Survival rates, 22, 38 283-295 Metastatic disease Non-Hodgkin’s lymphoma (See Lymphoma Ovarian cancer, screening, 330 (non-Hodgkin’s)) Prostate cancer, lymph node involvement, evaluation and radiotherapeutic management of, 224-227 Oo Tumors of unknown origin, 96-115 Oncology, autopsy in (Opinion), 47-56 Mouth cancer Incidence, 30 Opinion Mortality, 31 The Autopsy in Oncology, 47-56 Multiple myeloma Optic nerve and visual pathway gliomas Incidence, 30 Neurofibromatoses, 245-246 Mortality, 31 Mortality, African Americans, 13 Oral cavity cancer Survival rates, 38 Incidence, 21, 30, 33, 128 Incidence, African Americans, 7, 9 N Mortality, 21, 31, 32, 34 Mortality, African Americans, 8, 12, 13 Staging, African Americans, 15 National Cancer Data Base, Annual Review Staging, diagnosis, 23 of Patient Care Reports, 256 Survival rates, 22, 38 National Cancer Data Base (NCDB), breast Oral contraceptive, ovarian cancer cancer, surgical management, 39 prevention, 326 (Guest Editorial) VOL. 42,NO.6 NOVEMBER/DECEMBER 1992 Orthopedic manifestations, Mortality, 31 neurofibromatoses, 246 Staging, diagnosis, 23 Survival rates, 22, 38 Ovarian cancer Biologic therapy, 341-343 Podophyllotoxins, ovarian cancer Challenge of ovarian cancer, the 325-326 chemotherapy, 338 (Guest Editorial) Chemotherapy, 332, 334-341 Polypectomy, technique of, colonoscopy, Chemotherapy, autologous bone marrow 360-361 transplantation/chemotherapy trials, 340-341 Chemotherapy, carboplatin, 332, 334 Poorly differentiated carcinoma, tumors of Chemotherapy, dose intensity, 338 unknown origin, 106-113 Chemotherapy, drug resistance, 338-340 Chemotherapy, hexamethyimelamine, Poorly differentiated neoplasm, tumors of 336-337 unknown origin, 96-99 Chemotherapy, ifosfamide, 336 Chemotherapy, intraperitoneal, 340 Prevention (See Early cancer detection/ Chemotherapy, new drugs, sulofenur, 341 prevention) Chemotherapy, podophyllotoxins, 338 Chemotherapy, taxol, 334-336 Primary central nervous system lymphoma Hormonal therapy, 341 (PCL), human immunodeficiency virus (HIV), Immunodiagnosis, 343 malignant neoplasms associated with, 84—85 Incidence, 21, 30, 327 Incidence, African Americans, 9 Mortality, 21, 25, 28, 31 Prostate cancer Mortality, African Americans, 13 Evaluation and radiotherapeutic Prevention, 331-332 management of, 223-240 Screening and treatment, 327-349 diagnosis and work-up, 223-224 Screening and treatment, genetic lymph node involvement, 224-227 screening, 328-329 overview, 223 Screening and treatment, overview, 327 primary evaluation, 227-229 Screening and treatment, serum tumor staging, 229 marker screening, 331 transurethral resection effect, 224 Screening and treatment, ultrasonographic treatment, 229-238 screening, 329-331 Incidence, 21, 30, 33, 128 Staging, diagnosis, 23 Incidence, African Americans, 7, 9 Survival rates, 22, 38, 327 Mortality, 21, 25, 29, 31, 32, 34 Mortality, African Americans, 7, 10, 12 Prostatectomy, radical, role of, in treatment, 212-222 P Screening, current trends and future implications, 198-211 digitial rectal examination, 199-200 Pancreatic cancer overview, 198-199 Incidence, 21, 30, 33, 128 prostate-specific antigen, 202—209 Incidence, African Americans, 7, 9 ultrasonography and, 200-202 Mortality, 21, 25, 28, 29, 31, 32 Screening and treatment, American Mortality, African Americans, 7, 8, 10, 11, Cancer Society’s commitment, 197 12,13 (Editorial) Survival rates, 38 Staging, African Americans, 15 Staging, diagnosis, 23 Partial mastectomy, breast cancer, surgical Survival rates, 22, 38 management of, regional differences, 39-43 Perioperative endoscopy, colonoscopy Prostatectomy (radical), 212—222 indications, 355-356 indications for, 213-215 overview of, 212-213 Peritoneal carcinomatosis, tumors of procedure described, 215-221 unknown origin, adenocarcinoma, 100-101 sequelae of, 236, 237 Pharyngeal cancer Prostate-specific antigen, prostate cancer, Incidence, 30 screening for, 202—209 CA-A CANCER JOURNAL FOR CLINICIANS Protocol studies, autopsy in oncology evaluation and radiotherapeutic (Opinion), 51 management of, 226-227 Psychosocial factors Rectal cancer (See Colorectal cancer) Autopsy in oncology (Opinion), 53-54 Breast-conservation treatment, 161 Renal complications, childhood cancer, Childhood leukemia, neuropsychological long-term survivors of, 272-273 and psychosocial effects of treatment, 283-295 Renal pelvis cancer, survival rates, 38 Prostatectomy (radical), procedure described, 220-221 Pulmonary complications, childhood Ss cancer, long-term survivors of, 270-272 Screening African Americans, 14, 16 Breast cancer, American Cancer Society Q Guidelines on Screening for Breast Cancer: An Overview, 177-180 Quality assurance, autopsy in oncology Breast cancer, design and implementation (Opinion), 48-49 of community-based, 163-176 Breast cancer, detection and awareness, Questionable methods of cancer using a population-based cancer management, prevalence of, 181-191 reporting system to evauate, 367-371 Ovarian cancer, screening and treatment, 327-349 Prostate cancer, current trends and future implications, 198-211 R Prostate cancer, digital rectal examination, 199-200 Race differences Prostate cancer, treatment and, American Staging, local stage diagnosis, 15 Cancer Society’s commitment, 197 Survival rates, 22, 38 (Editorial) Radiation therapy Second cancer, childhood cancer, long- term Breast cancer (female), surgical survivors of, 275-277 management of, regional differences, 39-43 Serum tumor marker, ovarian cancer Breast-conservation treatment, screening, 331 146-155, 161 Childhood cancer, late adverse effects of Sex differences treatment among patients cured of, Incidence, 30 261-262 (Guest Editorial) Mortality, 25, 26,27, 28, 29, 34, 35 Childhood cancer, leukemia, Mortality, African Americans, 7, 8-9 neuropsychological and psychosocial effects of treatment, 283-295 Sexual function Childhood cancer, long-term survivors of, Childhood cancer, long-term survivors of, evaluation and identification of sequelae 265-267 of treatment, 263-282 Prostatectomy (radical), procedure Ewing’s sarcoma, 311-318 described, 220-221 Prostaie cancer, evaluation and radiotherapeutic management of, Skeletal metastases, tumors of unknown 223-240 origin, adenocarcinoma, 102 Radical prostatectomy (See Prostatectomy Skin cancer (radical)) Dermatofibrosarcoma protuberans, 116-125 Radiology (See also Mammography; Mortality, 25 Ultrasonography) Barium enema, colonoscopy and, Small intestine cancer 352-354 Incidence, 30 Prostate cancer, lymph node involvement, Mortality, 31 VOL. 42,NO.6 NOVEMBER/DECEMBER 1992 Smooth muscle tumor, human Breast cancer (female), standards for immunodeficiency virus (HIV), malignant breast-conservation treatment, neoplasms associated with, 90 landmark report, 133 (Editorial) Colonoscopy indications, perioperative Socioeconomic factors, statistics (African endoscopy, 355-356 Americans), 14, 15 Prostate cancer, prostatectomy, radical, 212-222 Spectrophotometer, new instrument for ultrarapid cell analysis (Classic), 57-63 Surveillance, colonoscopy indications, 334-336 Squamous carcinoma, tumors of unknown origin, 103-106 T Staging Breast cancer (female), surgical management of, regional differences, 39-43 Taxol, ovarian cancer chemotherapy, Ovarian cancer, 325-326 (Guest Editorial) 334-336 Prostate cancer, evaluation and radiotherapeutic management of, 229 T-cell lymphoma, human immunodeficiency Race differences, local stage diagnosis, 15 virus (HIV), malignant neoplasms associated with, 86, 89 Standards for breast-conservation treatment, landmark report, 133 (Editorial) Testicular cancer Incidence, 30 Statistics, 19-38 Mortality, 31 Autopsy in oncology (Opinion), 51-52 Survival rates, 38 Incidence, 19, 21, 30, 33, 128 Mortality, 19-20, 21, 24, 25, 26, 27, 28, 29, Thermal burns, colonoscopy complications, 360 31, 32, 34, 35, 36 Staging, 23 Thyroid cancer Survival rates, 20, 22, 37, 38 Wordwide, 20, 34, 35 Incidence, 30 Mortality, 31 Survival rates, 38 Statistics (African Americans), 7-17 Childhood cancers, 16 Thyroid dysfunction, childhood cancer, Geographical differences, 9, 14 long-term survivors of, 268-269, 271, 276 Incidence, 7 Mortality, 7-9, 10, 11, 12, 13 Tongue cancer Overview, 7 Screening, 14, 16 Incidence, 30 Socioeconomic factors, 14, 15 Mortality, 31 Survival rates, 14 Transurethral resection, prostate cancer, effects of, 224 Stomach cancer Incidence, 21, 30 Tumors of unknown origin, 96-115 Incidence, African Americans, 7, 9 Adenocarcinoma, 99-103 Mortality, 21, 28, 29, 31, 35 Poorly differentiated carcinoma, 106-113 Mortality, African Americans, 12, 13 Poorly differentiated neoplasm, 96-99 Staging, diagnosis, 23 Squamous carcinoma, 103-106 Survival rates, 22, 38 Sulofenur, ovarian cancer chemotherapy, 341 U Surgical management Ultrarapid cell analysis, spectrophotometer, Bowel resection, colonoscopy, 1087-1088 new instrument for (Classic), 57-63 Breast cancer (female), regional differences, 39-43 Ultrasonography (See also Mammography; Breast cancer (female), standards for Radiology) breast-conservation treatment, Breast-conservation treatment, 155-156 134-162 Colonoscopy and, future uses, 362 CA-A CANCER JOURNAL FOR CLINICIANS